home / stock / aplt / aplt news

APLT News and Press, Applied Therapeutics Inc. From 02/15/24

Stock Information
Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NYSE
Website: appliedtherapeutics.com
Menu
APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...
APLT - APLT, BLZE and CORZZ are among after hour movers

2024-02-15 17:12:12 ET Gainers: The Trade Desk ( TTD ) +20% . Applied Materials ( AMAT ) +11% . Coinbase Global ( COIN ) +11% . Backblaze ( BLZE ) +9% . Texas Roadhouse ( TXRH ) +6% . Losers: Roku ( ROKU ) -16% . ...
APLT - American Well, West Pharmaceutical Services among healthcare movers

2024-02-15 10:00:00 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...

APLT - APLT Reports Positive Phase 3 Trial Results from Interim Analysis of Govorestat

2024-02-15 09:29:01 ET DENVER, Colo., Feb 15, 2024 (www.247marketnews.com) – Applied Therapeutics, Inc. (NASDAQ: APLT ) reported, this morning, achieving primary endpoints and several key secondary endpoints in its interim 12-month results from the ongoing Phase 3 INSPIRE trial, ...

APLT - Applied Therapeutics gains as late-stage trial for lead asset succeeds

2024-02-15 08:24:49 ET More on Applied Therapeutics Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Gene...
APLT - Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite (p=0.05) Sustained, statistically significant reduction in sorbitol in govorestat-treated patients vs. placebo (p<0.001) Highly statistically significan...

APLT - Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)

2024-01-08 08:19:00 ET Summary APLT had a considerable run-up since my prior coverage. APLT remains undervalued based on just the galactosemia thesis. However, now the short-term risk has increased considerably, for numerous reasons. AT-001 failed to meet the primary endpoint...

APLT - PETS, NVTS and GRTS are among after hour movers

2024-01-05 16:47:44 ET Gainers: Credo Technology Group Holding  ( CRDO ) +3% . Gritstone  ( GRTS ) +3% . PetMed Express ( PETS ) +3% . Navitas Semiconductor Corporation ( NVTS ) +2% . Intuitive Machines ( LUNR ) +2% . ...
APLT - RCAC, AIMD and MESO among mid-day movers

2024-01-05 12:31:54 ET Gainers: Revelstone Capital Acquisition Corp ( RCAC ) +90% . Ainos ( AIMD ) +72% . Banzai International ( BNZI ) +62% . Safe and Green Development ( SGD ) +41% . Swvl Holdings ( SWVL ) +41% . Zoomcar Ho...

APLT - Cyclacel Pharmaceuticals, Angiodynamic among healthcare movers

2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

APLT - Biggest stock movers today: Peloton, Medical Properties Trust, and more

2024-01-05 05:29:04 ET Stock futures inched lower in the early hours of Friday ahead of the December jobs report. Here are some of Friday's biggest stock movers: Biggest stock gainers For further details see: Biggest stock movers today: Peloton, Medical Properties Trust, and...
Previous 10 Next 10